Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19
Standard
Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19. / Kaltschmidt, Barbara; Fitzek, Antonia D E; Schaedler, Julia; Förster, Christine; Kaltschmidt, Christian; Hansen, Thorsten; Steinfurth, Fabian; Windmöller, Beatrice A; Pilger, Christian; Kong, Cihang; Singh, Kashika; Nierhaus, Axel; Wichmann, Dominic; Sperhake, Jan; Püschel, Klaus; Huser, Thomas; Krüger, Martin; Robson, Simon C; Wilkens, Ludwig; Schulte Am Esch, Jan.
In: CLIN GASTROENTEROL H, Vol. 19, No. 8, 08.2021, p. 1726-1729.e3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19
AU - Kaltschmidt, Barbara
AU - Fitzek, Antonia D E
AU - Schaedler, Julia
AU - Förster, Christine
AU - Kaltschmidt, Christian
AU - Hansen, Thorsten
AU - Steinfurth, Fabian
AU - Windmöller, Beatrice A
AU - Pilger, Christian
AU - Kong, Cihang
AU - Singh, Kashika
AU - Nierhaus, Axel
AU - Wichmann, Dominic
AU - Sperhake, Jan
AU - Püschel, Klaus
AU - Huser, Thomas
AU - Krüger, Martin
AU - Robson, Simon C
AU - Wilkens, Ludwig
AU - Schulte Am Esch, Jan
PY - 2021/8
Y1 - 2021/8
N2 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects the nasopharynx and lungs and causes coronavirus disease-2019 (COVID-19). It may impact the heart, brain, kidney, and liver.1 Although functional impairment of the liver has been correlated with worse clinical outcomes, little is known about the pathophysiology of hepatic injury and repair in COVID-19.2,3 Histologic evaluation has been limited to small numbers of COVID-19 cases with no control subjects2,4 and demonstrated largely heterogeneous patterns of pathology.2,3.
AB - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects the nasopharynx and lungs and causes coronavirus disease-2019 (COVID-19). It may impact the heart, brain, kidney, and liver.1 Although functional impairment of the liver has been correlated with worse clinical outcomes, little is known about the pathophysiology of hepatic injury and repair in COVID-19.2,3 Histologic evaluation has been limited to small numbers of COVID-19 cases with no control subjects2,4 and demonstrated largely heterogeneous patterns of pathology.2,3.
U2 - 10.1016/j.cgh.2021.01.044
DO - 10.1016/j.cgh.2021.01.044
M3 - SCORING: Journal article
C2 - 33516952
VL - 19
SP - 1726-1729.e3
JO - CLIN GASTROENTEROL H
JF - CLIN GASTROENTEROL H
SN - 1542-3565
IS - 8
ER -